Treatment or prophylaxis of insulinproducing cell graft rejection

Details for Australian Patent Application No. 2002320828 (hide)

Owner Novartis AG

Inventors Mullon, Claudy; Lake, Philip

Agent Davies Collison Cave

Pub. Number AU-B-2002320828

PCT Number PCT/EP02/06278

PCT Pub. Number WO2002/100148

Priority 60/297,069 08.06.01 US

Filing date 7 June 2002

Wipo publication date 23 December 2002

Acceptance publication date 2 February 2006

International Classifications

C07D 409/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

Event Publications

16 January 2003 Complete Application Filed

  Priority application(s): 60/297,069 08.06.01 US

15 May 2003 Application Open to Public Inspection

  Published as AU-B-2002320828

2 February 2006 Application Accepted

  Published as AU-B-2002320828

8 June 2006 Standard Patent Sealed

7 January 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002320829-DEVICE FOR CUTTING HEDGES

2002320827-CHANGE-OVER GEAR FOR GARDEN SHEARS